0.67 | 1.47%
BALCHEM CORP's gross profit margin for the first quarter of its fiscal year 2013 is essentially unchanged when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not. BALCHEM CORP is extremely liquid. Currently, the Quick Ratio is 7.39 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 18.32% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
| Income Statement | Q1 FY13 | Q1 FY12 |
|---|---|---|
| Net Sales ($mil) | 84.65 | 76.2 |
| EBITDA ($mil) | 18.49 | 16.1 |
| EBIT ($mil) | 15.87 | 13.68 |
| Net Income ($mil) | 10.89 | 9.27 |
| Balance Sheet | Q1 FY13 | Q1 FY12 |
|---|---|---|
| Cash & Equiv. ($mil) | 149.09 | 121.29 |
| Total Assets ($mil) | 323.06 | 278.12 |
| Total Debt ($mil) | 0.0 | 1.19 |
| Equity ($mil) | 288.07 | 243.45 |
| Profitability | Q1 FY13 | Q1 FY12 |
|---|---|---|
| Gross Profit Margin | 31.72 | 30.94 |
| EBITDA Margin | 21.83 | 21.12 |
| Operating Margin | 18.74 | 17.95 |
| Sales Turnover | 0.99 | 1.06 |
| Return on Assets | 12.88 | 14.06 |
| Return on Equity | 14.44 | 16.06 |
| Debt | Q1 FY13 | Q1 FY12 |
|---|---|---|
| Current Ratio | 8.42 | 7.02 |
| Debt/Capital | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 |
| Interest Coverage | 15865.0 | 4558.33 |
| Share Data | Q1 FY13 | Q1 FY12 |
|---|---|---|
| Shares outstanding (mil) | 29.66 | 29.26 |
| Div / share | 0.0 | 0.0 |
| EPS | 0.36 | 0.31 |
| Book value / share | 9.71 | 8.32 |
| Institutional Own % | n/a | n/a |
| Avg Daily Volume | 80740.0 | 82205.0 |
BUY. This stock's P/E ratio indicates a premium compared to an average of 29.42 for the Chemicals industry and a significant premium compared to the S&P 500 average of 19.08. Conducting a second comparison, its price-to-book ratio of 4.86 indicates a significant premium versus the S&P 500 average of 2.44 and a premium versus the industry average of 4.15. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, BALCHEM CORP proves to trade at a premium to investment alternatives within the industry.
| Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCPC 34.23 | Peers 29.42 | BCPC 30.67 | Peers 14.61 | |||||||||||||||||||||
|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations. BCPC is trading at a premium to its peers. |
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. BCPC is trading at a significant premium to its peers. |
|||||||||||||||||||||||
| Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
| BCPC 24.23 | Peers 17.49 | BCPC 1.67 | Peers 1.31 | |||||||||||||||||||||
|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations. BCPC is trading at a significant premium to its peers. |
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. BCPC trades at a significant premium to its peers. |
|||||||||||||||||||||||
| Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
| BCPC 4.86 | Peers 4.15 | BCPC 6.15 | Peers 5.58 | |||||||||||||||||||||
|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. BCPC is trading at a premium to its peers. |
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. BCPC is expected to have an earnings growth rate that exceeds its peers. |
|||||||||||||||||||||||
| Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
| BCPC 4.39 | Peers 2.18 | BCPC 8.05 | Peers 4.20 | |||||||||||||||||||||
|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. BCPC is trading at a significant premium to its industry. |
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share. BCPC has a sales growth rate that significantly exceeds its peers. |
|||||||||||||||||||||||
